查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602750

动物生物技术市场：按产品、按应用分类 - 2025-2030 年全球预测

Animal Biotechnology Market by Product (Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs), Application (Development of Animal Pharmaceuticals, Food Safety & Drug Development, Preventive Care for Animals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年动物生物技术市场的市场规模为286.4亿美元，预计到2024年将达到310.4亿美元，复合年增长率为8.46%，到2030年将达到505.9亿美元。

动物生物技术包括将科学和工程原理应用于动物或其生物实体的物质加工或生产，以改善动物繁殖、健康、生产力和效率。该部门专注于基因工程产品，这些产品能够承受环境压力，生产更有营养的牛奶和肉类，并提供客製化的生物解决方案，以满足全球食品需求、药品和农业生产力，这些对于发展增强的动物至关重要。该领域的应用范围包括基因工程、克隆和生物製药生产。最终用途包括农业、製药和旨在改善动物健康和生产效率的研究机构。

主要市场统计
基准年[2023] 286.4亿美元
预测年份 [2024] 310.4亿美元
预测年份 [2030] 505.9亿美元
复合年增长率（%） 8.46%

市场成长受到全球人口成长、对粮食安全日益关注以及向永续农业流程转变的影响。基因组学和 CRISPR/Cas9 等基因编辑技术等生物技术创新正在推动进步，并为作物和牲畜的稳健做出贡献。然而，牲畜疾病管理、生物製药生产和提高动物福利标准也存在潜在机会。投资研发的公司可以利用与学术和研究机构的伙伴关係来促进创新并扩大其产品线。市场面临道德争论、严格的法律规范和有限的消费者意识等挑战，可能会阻碍快速采用。解决这些限制需要透明地沟通利益、风险和道德考虑因素，以及强有力的监管策略以确保接受和合规。

具有技术创新潜力的领域包括次世代定序、基因编辑的进步以及精准畜牧业的综合生物资讯学。此外，专注于全球协作和跨行业伙伴关係可以增强多元化和可扩展性。这个市场的本质是动态的，强调永续实践和道德考量。寻求发展的公司必须保持敏捷，应对复杂的动物生物技术领域，同时促进创新和监管合规。透过解决道德和监管问题并培养消费者信任，公司可以抓住畜牧业和医疗解决方案领域对生物技术进步不断增长的需求。

市场动态：揭示快速发展的动物生物技术市场的关键市场洞察

供需的动态交互作用正在改变动物生物技术市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 人们越来越关注克隆和基因改造动物
    • 越来越受欢迎和接受以及监管部门的核准
    • 动物用药品开发及动物预防医疗
  • 市场限制因素
    • 与动物生物技术产品相关的高成本伦理问题
  • 市场机会
    • 肉品消费量增加，人均动物医疗费用增加
    • 农业基因改造牲畜的生产
  • 市场问题
    • 食品对人体的潜在健康影响

波特五力：驾驭动物生物技术市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解动物生物技术市场的外部影响

外部宏观环境因素在塑造动物生物技术市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解动物生物技术市场的竞争格局

对动物生物技术市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：动物生物技术市场供应商的绩效评估

FPNV 定位矩阵是评估动物生物技术市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划动物生物技术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对动物生物技术市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人们越来越关注克隆和基因改造动物
      • 越来越受欢迎和接受以及监管部门的核准
      • 动物用药品开发和动物预防保健
    • 抑制因素
      • 与动物生物技术产品相关的高成本伦理问题
    • 机会
      • 动物肉类消费量增加，人均动物医疗费用上升
      • 农业基因改造牲畜的生产
    • 任务
      • 食品对人类健康的潜在影响
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章动物生物技术市场：副产品

  • 介绍
  • 诊断测试
  • 药品
  • 生殖和遗传产品
  • 疫苗

第七章动物生物技术市场：依应用分类

  • 介绍
  • 动物用药品开发
  • 食品安全和药物开发
  • 预防保健

第八章美洲动物生物技术市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太动物生物技术市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲动物生物技术市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Bayer AG
  • BioChek BV
  • Biogenesis Bago
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Intervet Inc.
  • Kareo, Inc.
  • Merck & Co., Inc.
  • Sanofi-Aventis Groupe SA
  • Santa Cruz BIoTechnology, Inc.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-437517DB6EAD

The Animal Biotechnology Market was valued at USD 28.64 billion in 2023, expected to reach USD 31.04 billion in 2024, and is projected to grow at a CAGR of 8.46%, to USD 50.59 billion by 2030.

Animal biotechnology encompasses the application of scientific and engineering principles to the processing or production of materials by animals or their biological entities, aiming to improve animal breeding, health, productivity, and efficiencies. This field is essential for developing genetically enhanced animals that can withstand environmental stresses, produce more nutritionally enriched milk or meat, and provide biologically based solutions tailored to address global food demands, pharmaceuticals, and agricultural productivity. Applications in this area extend to genetic engineering, cloning, and the production of bio-pharmaceuticals. The end-use scope covers agriculture, pharmaceuticals, and research institutions seeking to enhance animal health and production efficiencies.

KEY MARKET STATISTICS
Base Year [2023] USD 28.64 billion
Estimated Year [2024] USD 31.04 billion
Forecast Year [2030] USD 50.59 billion
CAGR (%) 8.46%

Market growth is influenced by the rising global population, increasing food security concerns, and the shift towards sustainable agricultural processes. Biotechnology innovations such as genomics and gene-editing technologies like CRISPR/Cas9 drive advancements, contributing to crop and livestock robustness. However, potential opportunities lie in disease management in livestock, biopharmaceutical production, and improving animal welfare standards. Companies investing in research and development can leverage partnerships with academic and research institutions to foster innovation and expansive product lines. The market faces challenges like ethical debates, stringent regulatory frameworks, and limited consumer awareness, which may impede rapid adoption. Addressing these limitations requires transparent communication about benefits, risks, and ethical considerations, in conjunction with robust regulatory strategies to ensure acceptance and compliance.

The potential areas for innovation include next-generation sequencing, gene-editing advancements, and integrative bioinformatics for precision animal farming. Furthermore, focusing on global collaborations and cross-industry partnerships could bolster diversification and scalability. The nature of this market is dynamic, with a strong emphasis on sustainable practices and ethical considerations. Companies seeking growth must remain agile, fostering innovation and regulatory compliance to navigate the complex landscape of animal biotechnology. By addressing ethical and regulatory concerns and cultivating consumer trust, businesses can tap into the burgeoning demand for biotechnological advancements in animal agriculture and healthcare solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Biotechnology Market

The Animal Biotechnology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising focus toward cloning and transgenic animals
    • Growing popularity and acceptance coupled with the regulatory approvals
    • Development of animal pharmaceuticals and preventive care for animals
  • Market Restraints
    • High cost ethical issues associated with the animal biotechnology products
  • Market Opportunities
    • Increasing animal meat consumption and the rising per capita animal healthcare expenditure
    • Production of transgenic livestock for agriculture
  • Market Challenges
    • Potential health effects to humans from food product

Porter's Five Forces: A Strategic Tool for Navigating the Animal Biotechnology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Biotechnology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Biotechnology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Biotechnology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Biotechnology Market

A detailed market share analysis in the Animal Biotechnology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Biotechnology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Biotechnology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Biotechnology Market

A strategic analysis of the Animal Biotechnology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Biotechnology Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, BioChek BV, Biogenesis Bago, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Intervet Inc., Kareo, Inc., Merck & Co., Inc., Sanofi-Aventis Groupe S.A., Santa Cruz Biotechnology, Inc., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Biotechnology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs, and Vaccines.
  • Based on Application, market is studied across Development of Animal Pharmaceuticals, Food Safety & Drug Development, and Preventive Care for Animals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising focus toward cloning and transgenic animals
      • 5.1.1.2. Growing popularity and acceptance coupled with the regulatory approvals
      • 5.1.1.3. Development of animal pharmaceuticals and preventive care for animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost ethical issues associated with the animal biotechnology products
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing animal meat consumption and the rising per capita animal healthcare expenditure
      • 5.1.3.2. Production of transgenic livestock for agriculture
    • 5.1.4. Challenges
      • 5.1.4.1. Potential health effects to humans from food product
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Biotechnology Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Tests
  • 6.3. Drugs
  • 6.4. Reporductive & Genetic Produtcs
  • 6.5. Vaccines

7. Animal Biotechnology Market, by Application

  • 7.1. Introduction
  • 7.2. Development of Animal Pharmaceuticals
  • 7.3. Food Safety & Drug Development
  • 7.4. Preventive Care for Animals

8. Americas Animal Biotechnology Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Animal Biotechnology Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Animal Biotechnology Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer AG
  • 2. BioChek BV
  • 3. Biogenesis Bago
  • 4. Boehringer Ingelheim International GmbH
  • 5. Elanco Animal Health Incorporated
  • 6. Heska Corporation
  • 7. Hester Biosciences Limited
  • 8. IDEXX Laboratories, Inc.
  • 9. Indian Immunologicals Ltd.
  • 10. Intervet Inc.
  • 11. Kareo, Inc.
  • 12. Merck & Co., Inc.
  • 13. Sanofi-Aventis Groupe S.A.
  • 14. Santa Cruz Biotechnology, Inc.
  • 15. Virbac S.A.
  • 16. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL BIOTECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL BIOTECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL BIOTECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REPORDUCTIVE & GENETIC PRODUTCS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DEVELOPMENT OF ANIMAL PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FOOD SAFETY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PREVENTIVE CARE FOR ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023